Comparing Intermittent Fasting and Mediterranean Diet for Obesity
NCT ID: NCT07250659
Last Updated: 2025-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2022-09-01
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: A total of 120 adults diagnosed with obesity were enrolled. Baseline data on physical activity and dietary intake were collected through structured interviews. Participants were randomly assigned to two groups for a 4-week intervention. The IF group followed a time-restricted eating schedule (16:8), while the MD group followed a structured plan of three main meals and three snacks daily. Both diets included a 500-calorie daily reduction from estimated energy needs. Anthropometric measurements were recorded at baseline and week 4.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Intermittent Fasting and Mediterranean Diet on the Physical Health of the Elderly
NCT06480669
Classic vs. High-Fat Intermittent Fasting Effects
NCT06515639
Metabolic Effects of Morning 16/8 Fasting
NCT04293003
Short Term Intermittent Fasting and Mediterranean Diet
NCT02148458
Effect of Intermittent Fasting (Month of Ramadan) on Health
NCT05571891
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intermittent fasting diet intervention group
4 week time restricted intermittent fasting diet protocol
Intermittent Fasting Diet
Participants follow a time-restricted eating pattern for 4 weeks, consuming all meals within an 8-hour eating window (from 1:00 PM to 9:00 PM) and fasting for the remaining 16 hours each day. During the feeding window, they consume two main meals and one snack based on ad libitum intake, without specific calorie restriction. Dietary guidance is provided at the start and mid-point of the protocol by a registered dietitian.
Mediterranean diet intervention group
4 week mediterranean diet protocol
Mediterranean Diet
Participants follow a 4-week Mediterranean diet protocol that is adapted from the PREDIMED criteria and the MedDietScore index. The diet emphasizes high consumption of vegetables, fruits, legumes, whole grains, nuts, and olive oil; moderate intake of fish and poultry; and limited consumption of red meat, dairy products, and sweets. A registered dietitian provides dietary counseling sessions at the beginning and midway through the intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intermittent Fasting Diet
Participants follow a time-restricted eating pattern for 4 weeks, consuming all meals within an 8-hour eating window (from 1:00 PM to 9:00 PM) and fasting for the remaining 16 hours each day. During the feeding window, they consume two main meals and one snack based on ad libitum intake, without specific calorie restriction. Dietary guidance is provided at the start and mid-point of the protocol by a registered dietitian.
Mediterranean Diet
Participants follow a 4-week Mediterranean diet protocol that is adapted from the PREDIMED criteria and the MedDietScore index. The diet emphasizes high consumption of vegetables, fruits, legumes, whole grains, nuts, and olive oil; moderate intake of fish and poultry; and limited consumption of red meat, dairy products, and sweets. A registered dietitian provides dietary counseling sessions at the beginning and midway through the intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* absence of chronic diseases
* no regular use of medications
* non smokers
* non alcohol users
* not pregnant or breastfeeding
* no history of bariatric surgery
* no significant weight fluctuations (±5 kg) in the past 6 months
* no pregnancy plans during the study period
Exclusion Criteria
* Presence of any diagnosed chronic disease (e.g., diabetes, cardiovascular disease, thyroid disorders, renal or hepatic disease)
* Regular use of medications that could affect metabolism, appetite, or body weight
* Smoking or alcohol consumption
* Pregnancy or breastfeeding during the study period
* History of bariatric or other weight-related surgical procedures
* Significant weight changes (gain or loss ≥5 kg) within the past 6 months
* Planning pregnancy during the study period
* Inability or unwillingness to comply with dietary intervention and follow-up requirements
20 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kamil Dağcılar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kamil Dağcılar
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
European University of Lefke
Lefka, , Cyprus
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BAYEK011.02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.